Injectable Drug Delivery Devices Market Share

  • Report ID: 3277
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Injectable Drug Delivery Devices Market Share

By Product

  • Conventional Injection Devices
  • Advanced Injection Devices
    • Injectable Pens
    • Auto Injectors
    • Prefilled Syringe
    • Needle-free Injectors
    • Others

By Therapeutic Area

  • Cardiovascular Disease
  • Diabetes
  • Oncology
  • Autoimmune Disorders
  • Others

By Route of Delivery

 

  • Intramuscular
  • Subcutaneous
  • Intra Dermal

By End User

 

  • Hospitals & Clinics
  • Homecare Settings
  • Others

Research Nester
Global-Healthcare-Expenditure-per-Capita
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3277
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of injectable drug delivery devices is assessed at USD 130.64 billion.

Injectable Drug Delivery Devices Market size was over USD 123.2 billion in 2024 and is projected to reach USD 300.52 billion by 2037, growing at around 7.1% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is set to dominate majority revenue share by 2037, propelled by increasing incidence of chronic disorders in the region.

The major players in the market are Baxter International Inc., Eli Lilly and Company, West Pharmaceutical Services Inc., Pfizer Inc., Schott AG, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample